Free Trial

ProShares UltraShort Nasdaq Biotechnology (BIS) News Today

ProShares UltraShort Nasdaq Biotechnology logo
$17.42 -0.24 (-1.36%)
(As of 11/20/2024 ET)
BIS ProShares UltraShort Nasdaq Biotechnology ETF
Investing Strategies for Market Crashes
ProShares UltraShort Dow30 DXD
ProShares UltraShort Bitcoin ETF
ProShares UltraPro Short QQQ
ProShares UltraShort Nasdaq Biotechnology (BIS)
ProFunds UltraShort NASDAQ-100 Svc
ProFunds UltraShort NASDAQ-100 Inv
NASDAQ Biotechnology Index .NBI : NASDAQ
Five Myths about Nasdaq Indexes
Biotech Bumble: ETFs Fall to 2014 Lows
Get ProShares UltraShort Nasdaq Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter.

Financial Prophecy (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

BIS Media Mentions By Week

BIS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIS
News Sentiment

0.00

0.57

Average

News Sentiment

BIS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIS Articles
This Week

0

0

BIS Articles
Average Week

Get ProShares UltraShort Nasdaq Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BIS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners